09:48 AM EST - Microbix Biosystems Inc. : Reports results for its third quarter ended June 30, 2020, with an increase of 141% in sales of Quality Assessment products. Total Q3 revenue was $2,898,328, a 7% decrease from Q3 2019 revenues of $3,110,615. Lower sales and fewer gross margin dollars in Q3 led to an operating loss & net loss of $440,233 versus an operating loss & net loss of $191,322 in Q3 2019. Microbix Biosystems Inc.
shares T.MBX are trading down $0.045 at $0.27.
